Abstract-A previous genetic analysis comparing the Dahl salt-sensitive (S) rat with the spontaneously hypertensive rat identified a major locus on chromosome 2 that influences proteinuria in the S rat. In the present study, blood pressure, proteinuria, and renal hemodynamics were evaluated in congenic strains with small segments of the protective spontaneously hypertensive rat genome on the S background. Proteinuria and renal function were significantly improved in the congenic strains compared with the S. The causative locus interval was narrowed to <375 kb on the basis of congenic strains, haplotype data, comparative mapping, and concordance with human genetic studies. Sequencing of the coding region of genes in this region identified 36 single nucleotide polymorphisms (13 nonsynonymous and 23 synonymous). Gene expression profiling indicated that only a few genes exhibited differential expression. Arhgef11, Pear1, and Sh2d2 were identified as important candidate genes that may be linked to kidney injury in the S rat. In particular, Arhgef11 plays an important role in the activation of the Rho-ROCK signaling pathway. Inhibition of this pathway using fasudil resulted in a significant reduction of proteinuria in treated S rats (compared with untreated S). However, no difference was observed between treated or untreated spontaneously hypertensive rat or congenic strains. The homologous region in humans was found to be associated with estimated glomerular filtration rate in the Candidate Gene Association Resource population. In summary, these findings demonstrate that allelic variants in Arhgef11, acting through the Rho-ROCK pathway, could influence kidney injury in the S as well as provide insight into human kidney disease. (Hypertension. 2012;60:1157-1168.) • Online Data Supplement
C hronic kidney disease (CKD) affects ≈10% of adults in the United States. 1 Those with CKD initially demonstrate some sign of kidney injury (usually defined by proteinuria), and as kidney injury worsens there can be a significant decline in kidney function that results in increased risk for renal failure, as well as cardiovascular disease. Extensive evidence supports the premise of genetic susceptibility for kidney disease. 2 The strong impact of genetics on kidney disease is highlighted by the significant disparity in the prevalence of kidney disease in blacks (≈4-fold increase) with hypertension or diabetes mellitus compared with whites. 3 A number of large-scale genome-wide association analysis have identified single nucleotide polymorphism (SNP) associated with kidney injury, but for the most part these studies only account for a very small change in renal injury or a decline in renal function (as reviewed). 4 Therefore, there is a critical need to identify new genes and signaling pathways that might be involved in susceptibility and progression of kidney injury.
The Dahl salt-sensitive (S) rat is a commonly used genetic model to study salt-sensitive hypertension. Moreover, the S rat develops significant kidney injury, including glomerulosclerosis, tubulointerstitial fibrosis, and vascular hypertrophy. 5 Kidney injury in the S rat becomes more severe as blood pressure is increased when challenged with a high-salt diet, 6, 7 similar to human patients who exhibit hypertensive nephrosclerosis. 8 In contrast, the spontaneously hypertensive rat (SHR) is resistant to hypertension-associated kidney injury. Using a segregating population derived from the S and SHR, we demonstrated previously that there were 9 genomic regions associated with kidney injury in the S rat. 7, 9 Some genomic intervals were associated with both increased blood pressure and kidney injury, whereas other regions appeared to influence kidney injury independent of blood pressure changes. In particular, the locus on rat chromosome 2 demonstrated strong linkage (logarithm of the odds >12) and accounted for a large amount of variation in proteinuria. Recombinant progeny testing (RPT) narrowed the region of interest on chromosome 2 to ≈6 Mb.
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The homologous region on human chromosome 1 has also been associated with various types of kidney disease. 10, 11 However, the sequence variants, genes, and/or signaling pathways linked to this locus remain to be determined in rats or humans.
The present study used RPT, congenic strains, haplotype analysis, sequencing, and gene expression to establish a small number of genetic variants associated with increased susceptibility of the S rat to develop kidney injury and associated decline in kidney function. The first aim was to characterize the blood pressure and renal parameters associated with the gene or genetic variants within the quantitative trait locus for proteinuria on chromosome 2. Thus, temporal changes in blood pressure, proteinuria, and renal hemodynamics were evaluated by comparing S rats with 2 congenic strains carrying small SHR chromosome 2 segments. The second aim sought to identify sequence variants and gene expression differences in genes located in the newly identified small genomic segment. Finally, to validate the importance of the genetic locus, the candidate region was evaluated using a large-scale human population of CKD patients.
Methods
Detailed information on material and methods are provided in the online-only Data Supplement.
Animals and Study Design
All experiments were approved by the institutional animal care and use committee at either the Medical College of Wisconsin or the University of Mississippi Medical Center. The Dahl S and the SHR inbred strains are maintained at our institutional animal facility.
Study 1: Fine-Mapping Using RPT and Congenic Strains
RPT was used to fine-map the proteinuria locus, as done previously. 12 Proteinuria was determined at week 8 in 6 recombinant families (X39, n=67; X40, n=38; X41, n=37; X42, n=37; X43, n=21; X44, n=23) (Table S1 in the online-only Data Supplement). The congenic strains, S.SHR(2) X39 and X47, were developed from the recombinant families by fixing the transferred genomic interval in the homozygous SHR/SHR state ( Figure 1 ). These congenic strains were used for studies 2 to 6.
Study 2: Proteinuria, Blood Pressure, and Renal Hemodynamic Parameters
At 4 weeks of age, groups of age-matched male S, S.SHR(2)X39, and SHR animals (n=6-8 per group) were weaned to a low-salt diet (0.3% NaCl; TD7034; Harlan Teklad, Madison, WI). At week 12, mean arterial pressure, renal blood flow (RBF), and glomerular filtration rate (GFR) were measured.
Study 3: Time Course Measurement of Proteinuria and Telemetry Blood Pressure
At 4 weeks of age, groups of age-matched male S and S.SHR(2)X47 rats (n=16 per group) were weaned to a low-salt diet (0.3% NaCl). Proteinuria and blood pressure were measured from week 8 to 20 at 4-week intervals. Blood pressure was measured using a telemetry system (Data Sciences International, St. Paul, MN) in S (n=8) and S.SHR(2)X47 (n=10) animals, as done previously. 13 
Study 4: Glomerular Permeability and Number
The reflection coefficient of albumin (σalb) was determined in isolated glomeruli from S and S.SHR(2)X39 raised on a low-salt diet (week 12) using modifications of the technique of Savin et al. 14 These experiments were performed using 4 to 5 rats per strain with a minimum of 20 glomeruli per rat (n=80-100 total glomeruli per group). The determination of glomeruli number was performed using direct maceration/counting method 15 using kidneys isolated at 2 time points (week 6 and week 12).
Study 5: Renal Function and Survival Curve
At 4 weeks of age, groups of age-matched male S and S.SHR(2)X39 animals (n=9 per group) were weaned to a normal rodent chow (0.7% NaCl; Purina 5010) to exacerbate hypertension and progression of injury compared with a low-salt diet. Proteinuria and creatinine clearance were determined at week 12. Mean arterial pressure, GFR, and RBF autoregulation were evaluated in a separate group of animals (n=7-8 per group). A survival study was performed on S, S.SHR(2) X39, and SHR rats (n=12 rats per group).
Study 6: Pharmacological Inhibition of Rho-ROCK Pathway
Groups of age-matched male S, S.SHR(2)X39, and SHR animals (n=11 per group) were weaned to a low-salt diet (0.3% NaCl) at week 4. At week 8, animals for each strain were randomly assigned to either control (n=5 per strain) or fasudil treatment (n=6 per strain). Fasudil (LC Laboratories) was provided in drinking water to achieve a low dose of ≈20 mg/kg per day. Proteinuria was determined at weeks 8, 10, and 12 after 24-hour urine collection.
Histological Assessment
Kidney tissue was fixed in zinc formalin and embedded in paraffin, cut into 4-µm sections, and stained with hematoxylin and eosin and/ or Masson trichrome. Glomerular injury and tubulointerstitial injury were assessed as described previously. 5, 16, 17 Immunohistochemistry was performed as described previously.
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Molecular Methods
Genotyping and Sequencing
Genomic DNA was used to genotype congenic strains or sequencing and prepared using a Wizard SV 96 Genomic DNA kit. Genotyping 12 and current refinement of kidney injury locus to a <2 Mb based on substitution analysis (red box). B, Enlargement of the genomic region and 2 small congenic strains important in delimiting the genomic region. The gray box denotes the location of QTL based on recombinant progeny testing ( Figure S2 ) and X47 strain. The red solid bars to the right of the physical map with relevant microsatellite markers indicate the extent of the spontaneously hypertensive rat-donor regions on the Dahl salt-sensitive genetic background. by guest on July 12, 2017 http://hyper.ahajournals.org/ Downloaded from was done using a fluorescent-based approach on a Beckman Coulter CEQ8000 XL capillary sequencer, as described previously. 12 For sequencing of coding regions of candidate genes, primers were designed from known databases (Table S2) .
Real-Time Polymer Chain Reaction and Multiplex Gene Expression
RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) and purified using Mini RNeasy kit (Qiagen,Valencia, CA). cDNA was obtained by reverse transcription using the SuperScript III FirstStrand Synthesis System for Real Time-polymer chain reaction (PCR) (Invitrogen, Carlsbad, CA). Gene expression was evaluated using SYBR-green dye chemistry on a Stratagene MX3000p RealTime PCR machine, Bio-Rad CFX96, and Beckman Coulter GeXP platform (minimum n=6 each strain).
Western Blot Analysis
Tissue homogenates were prepared in radioimmunoprecipitation assay lysis buffer (Santa Cruz Biotechnology) from kidney cortex isolated from S and S.SHR(2)X39 under study 5. Blots were prepared using standard methods and probed with Rho-ROCK pathway proteins (ARHGEF11, RhoA, ROCK1, LIMK1, and Cofilin) and appropriate secondary antibody and imaged using a Pierce ECL Substrate on ChemiDoc XRS+System (Bio-Rad).
Population Studies: Candidate Gene Association Resource Consortium
The Candidate Gene Association Resource (CARe) population was used to evaluate 22 SNPs in the homologous region to the kidney injury locus identified in the present study. The CARe consortium evaluated the association of renal function measures in ≈23 000 individuals of European descent 18 using the ITMAT-Broad-CARe (IBC) SNP array, a 50K SNP genotyping array of candidate genes and pathways related to cardiovascular, inflammatory, and metabolic phenotypes.
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Statistical Analysis
Statistical analysis was performed using SPSS (Chicago, IL) for described animal studies. RPT data were evaluated using an independent t test using SPSS. Congenic strain phenotype data (eg, proteinuria and blood pressure) were evaluated by t test and/or by one-analysis of variance followed by Bonferroni correction for multiple comparisons. A P<0.05 was considered to be statistically significant. All data are presented as mean±SE. Survival was evaluated by the Kaplan-Meier method (GraphPad Prism 5, La Jolla, CA). A detailed description of the statistical approach for the CARe Study is provided in expanded Material and Methods section.
Results
Fine-Mapping and Renal Hemodynamics
An overview of the approach used to fine-map and identify the genetic variants linked to the proteinuria locus (kidney injury) on chromosome 2 is shown in Figure S1 . RPT was previously used to localize the chromosome 2 genetic locus to an ≈6-Mb genomic interval (D2Arb11-D2Rat230). In the present study, RPT using additional recombinant families further refined the genetic locus (in the S rat) to ≈2.5 Mb ( Figure S2 and Table S1 ). Important recombinant animals were used to generate 2 small congenic strains (S.SHR(2)X39 and X47) to characterize the influence of blood pressure, proteinuria, and renal hemodynamic parameters associated with the kidney injury locus (Figure 1 ). At 12 weeks of age on a low-salt diet (0.3% NaCl), blood pressure was similar between strains. However, the S.SHR(2)X39 congenic demonstrated a ≈2-fold reduction in proteinuria and significantly higher GFR compared with S rat (Figure 2A) . The S.SHR(2)X47 strain exhibited significantly reduced proteinuria from week 8 to 20 and less kidney hypertrophy ( Figure S3 ). At week 20, proteinuria was 109.0±12.2 mg/24 h compared with the 161.0±11.8 in the S. Similar to SHR(2)X39, no significant difference in blood pressure was detected in the S.SHR(2)X47 compared with control S over the same period.
Proteinuria, renal hemodynamics, and survival were evaluated between the S and S.SHR(2)X39 on a normal rodent diet (0.7% NaCl) ( Figures 2B and S4) . The diet exacerbated hypertension and accelerated the severity of proteinuria in both strains compared with a low-salt diet. However, the S.SHR(2)X39 congenic still exhibited a significant reduction in proteinuria and improved kidney function (creatinine clearance) compared with S ( Figure 2B ). RBF remained relatively constant when renal perfusion pressure varied from 100 to 140 mm Hg ( Figure S4 ). Basal RBF was significantly higher in the congenic (4.40±0.33 mL/min per gram of kidney weight; P<0.05) compared with S (3.00±0.27); however, autoregulation of RBF was similar in the S and S.SHR(2)X39 strain ( Figure S4 ). Renal vascular resistance was significantly decreased in the congenic (37±3.4 mm Hg/mL per minute; P<0.05) compared with S (53.0±4.2). The median survival for S.SHR(2)X39 rats was 345 days compared with median survival of S rats (176 days, P<0.001), whereas no SHRs died during the course of the experiment ( Figure 2C ).
Glomerular Morphology and Renal Pathology
Representative histology is shown for S and S.SHR(2)X39 congenic rats in Figure 3 . Glomerular injury (mesangial expansion, glomerulosclerosis, etc) was significantly attenuated in the S.SHR(2)X39 strain compared with S, as was glomerular area, whereas increased glomerular hypertrophy was observed in S rats ( Figure 3B ). Increased glomerular area was significantly correlated with increased proteinuria (r=0.72, P<0.001). Nephron number was observed to be significantly increased in the congenic strain. Despite a significant difference in proteinuria between strains, glomerular permeability to fluorescein isothiocyanate-albumin was similar ( Figure S4 ). The extent of tubular injury and degree of interstitial fibrosis (tubule atrophy, immune cell infiltration, and/or fibrosis) was significantly reduced in the S.SHR(2)X39 ( Figure 3 ) and S.SHR(2)X47 ( Figure S3 ) compared with the S rats. No difference in medial thickness of the renal arterioles between strains ( Figure 3D ) was observed. The degree of interstitial injury was confirmed by decreased α-smooth muscle actin expression and macrophage infiltration observed in the S.SHR(2)X39 ( Figure 3E and 3F) and S.SHR(2)X47 ( Figure  S3 ) compared with the S rats.
Haplotype Analysis and Overlap With Human Kidney Disease Loci
Haplotype analysis was performed using a panel of inbred strains known to exhibit high or low proteinuria (Table S3 ). There was a strong concordance between the groups (high or low) and the allelic variant (C or T) at ENSRNOSNP2786652. The S, Munich Wistar Frömter, Buffalo, and Milan Normo tensive Strain (susceptible to proteinuria) all possess the C allele, whereas the SHR, Wistar Kyoto, August-Irish-Copenhagen, Fischer 344, Louvain, and Milan Hypertensive Strain (resistant to proteinuria) possess the T allele. The location of SNP is consistent with the region identified using substitution analysis (Figure 4) . However, the SNPs above and below ENSRNOSNP2786652 did not exhibit this pattern (Table S3) .
The region in humans that is homologous to the rat quantitative trait locus lies on both human chromosomes 1 and 4 ( Figure 4 ). The break point occurs around the middle of the rat genomic locus and provides additional confirmation and refinement of the genomic interval by comparative mapping, because only the homologous region on 1q21 is linked to several forms of kidney disease (Figure 4) .
Sequencing, Expression, and Prioritization of Candidate Genes
The coding regions of genes that map into the congenic interval were sequenced from S and SHR. A complete list of genes is shown in Table S4 . Only genes that exhibited sequence differences are shown in the Table. A total of 13 nonsynonymous (amino acid change) and 23 synonymous variants were identified in 16 genes. However, only 9 genes exhibited sequence differences in the refined genomic interval considering substitution analysis, haplotype, and comparative mapping data (summarized in Figure 4 ). More than half of the sequence variants (15 of 26) were found within 3 genes, Arhgef11, Pear1, and Iqgap3. Arhgef11 contained the most nonsynonymous variants (n=3), followed by Iqgap3 (n=2) and Pear1 (n=1).
The expression of genes in the kidney was evaluated using a multiplex approach ( Figure S5 ). Five genes (Arhgef11, Pear1, Sh2d2, Gpatch4, and Lrcc) were found to be differentially expressed (Table S5) . A subset of genes located in the refined interval were confirmed using real-time PCR at an early (week 4) and late (week12) time point under low-salt diet (0.3% NaCl) ( Figure 5A ). Arhgef11, Pear1, Sh2d2, and Nes were confirmed to be differentially expressed between strains, similar to the multiplex approach. Gene expression was also evaluated on isolated kidney cortex and medulla from animals exposed to a moderate increase in salt (0.7% NaCl). Arhgef11, Pear1, Sh2d2a, Nes, and Gpatch4 were again found to be Blood pressure, proteinuria, and renal hemodynamic parameters among Dahl salt-sensitive (S), S.SHR(2)X39, and spontaneously hypertensive rat (SHR). A, Mean arterial pressure (MAP), proteinuria, and glomerular filtration rate (GFR) at week 12 for animals (n=6-8 per group) raised on low salt. B, Proteinuria and creatinine clearance (CrCl) for animals raised on Purina 5010 (0.7% NaCl) diet (n=9 per group). C, Kaplan-Meier survival curve. For B and C, animals were raised on low salt (0.3% NaCl) until 6 weeks of age and then placed on Purina 5010 (0.7% NaCl) diet for duration of experiment to accelerate injury.*P<0.05 vs S and/or SHR. #P<0.05 vs S or S.SHR (2) To establish gene(s) that may have the greatest likelihood for involvement in influencing kidney injury, genes were evaluated on the basis of 3 criteria, including nature and type of sequence variation, differential expression, and/or possible biological role ( Figure S6 ). In short, genes designated as high priority are those that exhibited coding sequence variants that alter amino acids, differential expression, and evidence that the gene could have a biological role in the kidney. Arhgef11, Pear1, and Sh2d2 were identified as important candidate genes linked to kidney injury using this methodology ( Figure 4 ).
Western Blot Analysis of ARHGEF11, Rho-ROCK Pathway, and Inhibition by Fasudil
The potential role of ARHGEF11 in the Rho-ROCK pathway was evaluated by Western blot analysis, because this pathway is known to influence cardiovascular disease ( Figure 6A and 6B). Protein levels of ARHGEF11 were 1.6-fold higher in the S compared with the S.SHR(2)X39 congenic rat, consistent with detected gene expression differences ( Figure 5 ). RhoA, which is activated through exchange of GDP for GTP by ARHGEF11, was also increased in the S rat (1.5-fold), as were other downstream proteins (ROCK1, LIMK1, and p-Cofilin). Protein levels of ROCK1 demonstrated the greatest change (4.7 higher in the S rat).
The influence of the Rho-ROCK pathway on proteinuria was examined in the S, S.SHR(2)X39, and SHR using the ROCK inhibitor fasudil ( Figure 6C ). S rats treated with fasudil demonstrated a significant reduction in proteinuria compared with untreated S rats at weeks 10 and 12 (2 or 4 weeks of treatment). Proteinuria at week 12 for S-treated rats was similar to S.SHR(2)X39. No difference in proteinuria was detected between treated and untreated groups for either the S.SHR(2) X39 congenic or SHR.
Correlation of the Rat Locus With Human GWAS
Estimated glomerular filtration rate data were available for 23 247 individuals of European descent from the CARe Consortium. Among the 22 SNPs examined in the region . Summary of refinement of genomic locus using substitution analysis, comparative mapping, haplotype analysis, and identification of key genes. The gray box (left) denotes the location of the quantitative trait loci (QTL) based on recombinant progeny testing (RPT) ( Figure S2 ) and smallest congenic strain, S.SHR(2)X47( Figure 1 ). The region in humans that is homologous to the rat QTL lies on both human chromosomes 1 and 4 (middle). The break point (between 178.523 and 179.114 Mb) occurs around the middle of the rat QTL and provides a means to further refine the genomic interval. Human chromosome 1 has been linked to kidney disease: (1) adult-onset nephropathy and hypertension; 10 (2) MCDK, medullary cystic kidney disease [46] [47] [48] ; and (3) creatinine clearance (HyperGen Study), 11 whereas no human linkage or genome-wide association analysis (GWAS) studies have been associated with kidney disease on chromosome 4. The panel on the right shows important single nucleotide polymorphism (SNP) used for haplotype analysis (Table S3 ). The SNP shown in red demonstrated an association between high or low proteinuria strains, whereas those SNPs in blue did not. The underlined genes (Arhgef11, Pear1, and Sh2d2) were identified as high priority using gene priority decision tree ( Figure S6 ) and exhibit sequence variants that altered amino acid(s), exhibited differential expression, and linked to a possible biological role in the kidney. The remaining genes on the left of the physical map either exhibit sequence variants or differential expression. The genes on the right of the physical map exhibited no coding sequence variants or differential expression. The star denotes the SNP (rs7534418) associated with estimated glomerular filtration rate in the Candidate Gene Association Resource Study described in this study ( The italicized Ensembl transcript ID designates those genes residing in the refined genomic region based on congenic strain, haplotype analysis, and comparative mapping. Single nucelotide polymorphism (SNP) (ENSRNOSNP) important for haplotype analysis (Table S3 ) are also shown. Brown Norway (BN) is the rat genome reference sequence. S is Dahl salt-sensitive SS/jr and SHR is Spontaneously Hypertensive rat SHR/Hsd. Sequence variants highlighted in italics is the SNP. Each SNP was confirmed on ≥2 independent samples from each strain. Table S4 provides a summary of all genes in the genomic interval. The genes in bold in Table S4 were sequenced between S and SHR, and only those exhibiting a sequence difference are shown in this table.
by guest on July 12, 2017 http://hyper.ahajournals.org/ Downloaded from November 2012 homologous to the rat locus, a significant association with estimated glomerular filtration rate was observed for rs7534418 (P=0.001315, MAF=0.3269, β=0.0069 for each copy of the T allele) after Bonferroni correction ( Figure 7 ). Additional nominal associations (P<0.05) for several other SNPs (rs4661229, P=0.004; rs2768744, P=0.004) were also observed. For urine albumin:creatinine ratio (N=19 214), no associations in the region were observed ( Figure S7 ).
Discussion
We reported previously that a region on rat chromosome 2 was associated with proteinuria and histological renal injury but not blood pressure. 9 A congenic strain was developed (S.SHR (2)) to confirm the linkage analysis that demonstrated attenuated renal injury independent of changes in blood pressure compared with control S rats. 12 Subsequently, RPT narrowed the genomic interval based on overlapping recombinant intervals. 12 In the present study, we used additional RPT to better define the genomic interval, developed 2 small congenic strains to characterize the cardiovascular and renal parameters associated with the genomic locus, and performed detailed genetic analysis (haplotype analysis, sequencing, and gene expression) to identify genetic variants that may be causative to the observed renal injury.
Both congenic strains demonstrated reduced kidney injury and improved kidney function compared with the control S. The decreased proteinuria and improved GFR were associated with reduced renal inflammation and interstitial fibrosis in the absence of measurable differences in blood pressure between strains. Increased nephron number, along with elevated GFR in the S.SHR(2)X39 congenic, suggests that kidney development may play a role in the improved kidney function compared with the S rat, which exhibited significantly less nephrons. The connection between low nephron number and the risk of hypertension and kidney disease has been shown in humans and experimental animal models. 20 Glomerular permeability was similar between strains, despite the S.SHR(2) X39 congenic strain exhibiting an ≈40% reduction in proteinuria compared with the S rat. This suggests that the detected difference in proteinuria is not likely attributed to the degree of filtered protein but may likely reflect an increase in the reuptake of filtered protein in the proximal tubules. This finding is consistent with other genetic models of renal disease in which a large fraction of proteinuria is attributed to an impairment of protein reuptake via the proximal tubule without changes in glomerular permeability. 21 Classification of the nature and type of sequence variation, differential expression, and potential biological role identified NaCl) . B, Gene expression evaluated on isolated kidney cortex and medulla from animals exposed to a moderate increase in salt (0.7% NaCl). *, P<0.01. Ratio >1, S transcript expressed at higher level than congenic; Ratio <1, congenic expressed at higher level than S transcript. ND=not detected, n=6 per group. SHR indicates spontaneously hypertensive rat.
by guest on July 12, 2017 http://hyper.ahajournals.org/ Downloaded from 3 genes (Arhgef11, Pear1, and Sh2d2a) as important candidates for involvement in kidney injury. In general, allelic variants (promoter, coding, or intronic) in any of these genes could play important roles in influencing the onset or progression of kidney injury by altering gene expression, protein function, and/or alternative splicing. For example, PEAR1 is a novel membrane protein involved in platelet contact-induced activation. 22 Platelet activation and endothelial dysfunction have been mostly linked to atherosclerotic disease 23 and results in the secretion of several types of chemokines (MCP1, CCL5, CXCL4, etc). 24 The release of these chemokines triggers monocyte recruitment, differentiation into macrophages, 24 and perhaps immune-mediated renal injury. SH2D2A is a T-cell-specific adapter protein (or TSAd). Recent studies have indicated that it may function predominately in the nucleus where it acts to regulate the transcription of different T-cell target genes, including interleukin 2. 25 TSAd −/− deficient mice are susceptible to lupus-like autoimmune disease (when challenged with pristine) and demonstrate glomerulonephritis and proteinuria at an advanced age. 26 This type of renal injury is likely secondary to autoimmune disease by immune complexes becoming deposited in kidney glomeruli.
The most convincing evidence exists for Arhgef11 being involved in kidney injury in the Dahl S. ARHGEF11 is a RhoA guanine nucleotide exchange factor that participates in the Rho-ROCK pathway. The Rho-ROCK pathway has been implicated in a variety of pathological conditions, including cardiovascular disease and neurological disorders. 27, 28 The Rho family of small GTPases regulates a number of cell functions, including actin cytoskeletal organization, cell adhesion, cell motility, vascular smooth muscle contraction, and gene expression.
29 ARHGEF11 (PDZ-RhoGEF) binds activated α12/13 (G-protein) and demonstrates specificity for activating RhoA but not other Rho family members, Rac1 and Cdc42. 30 ARHGEF11 catalyzes the exchange of GDP for GTP, thereby activating RhoA. 31 The Rho effector protein, ROCK, is a serine-threonine kinase involved in both phosphorylation of myosin light chain, which can contribute to stress fiber formation and smooth muscle contraction. Arhgef11-deficient zebrafish embryos exhibit kidney cysts (along with other phenotypes), and the distribution of F-actin in the pronephric ducts is altered. 32 This work provides some evidence that ARHGEF11 can affect kidney development and play a role in stress fiber formation.
The Rho-ROCK pathway is modestly upregulated in the S (compared with S.SHR(2)X39), suggesting that chronic stimulation of the pathway may account for progressive kidney injury in the S rat. At this point, it is not clear whether the pathway is upregulated because of differential expression or protein function differences based on amino acid changes between the S and SHR. However, our data are consistent with other studies that support a role for Rho-ROCK with various aspects of renal disease, including alterations in afferent arteriolar tone (via vascular smooth muscle cells), 33 podocyte dysfunction, 34 and tubular epithelial mesenchymal transition leading to fibrosis (transforming growth factor-β mediated). 35, 36 There are 2 ROCK inhibitors available, Y-27632 and fasudil, both of which have been extensively used to investigate the role of Rho kinase in cardiovascular disease. 37 Both compounds attenuate tubulointerstitial fibrosis in a mouse model of 38 Inhibition of ROCK (fasudil) has also been shown to attenuate the development of glomerulosclerosis in the S rat. 39 Improvement in glomerulosclerosis was not accompanied by changes in blood pressure. 39 Inhibition of the Rho-ROCK pathway using fasudil significantly lowered proteinuria in S-treated versus nontreated rats, and no difference was observed between treated and nontreated congenic or SHR. This suggests that low-dose treatment with fasudil does not significantly affect the Rho-ROCK pathway in the congenic or SHR because these strains are able to correctly regulate the pathway. These findings demonstrate that allelic variants in Arhgef11, acting through the Rho-ROCK pathway, could modulate renal protection independent of changes in blood pressure (but function on a hypertensive susceptible genetic background).
The evaluation of the rat genomic locus using the human CKD CARe population supports our view that genetic variants/genes identified using rat models of renal disease may lead to a better understanding of genetic factors that contribute to kidney disease in humans. None of the candidate genes identified in the present study (Arhgef11, Pear1, or Sh2d2a) have been associated with proteinuria or GFR in humans until now. Several human studies have found an association with genetic variants in these genes with other types of cardiovascular, metabolic, or inflammatory diseases. In this regard, SNPs in ARHGEF11 have been linked to diabetes mellitus 40 and susceptibility to cerebrovascular disease (intracranial aneurysm).
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ROCK2 (a downstream target of ARHGEF11-RhoA) is associated with lower risk of hypertension in HYPGENE Study. 42 Genetic variants in PEAR1 are associated with increased platelet response, 43 and genetic variants in the promoter region of SH2D2A (short allele in promoter region) are linked with susceptibility to multiple sclerosis 44 and juvenile rheumatoid arthritis, 45 both chronic immune-mediated diseases.
Perspectives
Linkage analysis usually only identifies a broad genomic region linked to a particular trait, and subsequent finemapping is required to identify the causal genetic elements.
Ultimately, it is necessary to conduct detailed physiological studies using a small congenic strain to explore the mechanism linked to the causative gene or genetic variants. Here, we provided detailed information on cardiovascular and renal hemodynamic parameters associated with genetic variants on rat chromosome 2 that strongly influences the development of kidney injury in the S rat. It is clear that functional significance of the identified candidate genes and sequence variants will require more detailed analysis, but convincing evidence exists that Arhgef11 may be linked to kidney injury in the S via the Rho-ROCK signaling pathway. In summary, this work provides an advance in identifying genetic variants/genes that modulate the onset and progression of kidney disease in the setting of hypertension using the S rat and establishes relevance to human CKD using the CARe population.
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What Is New?
• First report on the high-resolution localization of a genomic locus linked to hypertensive related kidney disease using the S rat, a model of human chronic kidney disease.
• Few studies have performed, as we have, detailed physiological studies, histological analysis, comprehensive sequence, and gene expression analysis to investigate mechanism linked to a fine-mapped genetic locus for kidney injury.
• Identified a strong candidate gene (Arhgef11), not previously linked to the development of kidney injury in the rat and showed the locus around this gene was associated with estimated glomerular filtration rate in humans.
What Is Relevant? • Our genetic studies use 2 models of hypertension (S and SHR) that differ with respect to kidney injury. The advantage of this comparison is the ability to identify loci that influence kidney injury on genetic backgrounds (either S or SHR) permissive for hypertension.
• Hypertension is the second leading cause of renal failure in humans.
Thus, identification of gene/genetic variants related to kidney injury in the context of hypertension could have a significant impact on human health by serving as novel therapeutic targets.
Summary Our previous studies used the S rat to iden tify broad genomic intervals linked with cardiovascular and kidney disease. We now have successfully narrowed the genomic segment and identified specific genetic variants and genes on chromosome 2 linked with injury and reduced renal function. Thus, this work provides a significant advance in identifying genetic variants that contribute to the development of kidney disease in the setting of hypertension and establishes relevance to human chronic kidney dis1 ( Fig. S2, Table S1 ). At week 8, proteinuria was determined after 24-hour urine collection (Lab Products, Seaford, Delaware) in each recombinant family (X39, n=67; X40, n=38; X41, n=37; X42, n=37; X43, n=21; X44, n=23). The influence of each recombinant region (i.e. SHR genotype) was determined by subtracting average proteinuria of recombinant rats (SHR-like) from proteinuria of non-recombinant (S-like) littermates. A negative value indicates that rats containing SHR donor region (recombinant rats) exhibited lower proteinuria than nonrecombinant rats, and when statistically significant indicates that the genes or genetic variants that influence proteinuria are with the SHR donated region.
GENETIC VARIANTS IN ARHGEF11 ARE ASSOCIATED WITH KIDNEY INJURY IN THE DAHL S RAT
To allow for comprehensive phenotyping and analysis of the refined genomic interval, the S.SHR(2)X39 recombinant family was used to generate a congenic strain that fixed the transferred genomic interval homozygous SHR/SHR (Fig. 1) . The S.SHR(2)X47 was generated from a new recombination that occurred while developing the S.SHR(2)X39 strain. These congenic strains were utilized for Studies 2-6. (2) X47 rats (n=16 per group) were weaned to a low-salt diet (0.3% NaCl). Animals were studied from week 8 to 20. Blood pressure was measured by using a telemetry system (Data Sciences International, St. Paul, MN). At 7 weeks of age, animals were anesthetized using 2-3% isoflurane gas and a transmitter was surgically implanted in S (n=8) and S.SHR(2)X47 (n=10) animals. The probe body was placed 4 subcutaneously in the flank and the probe catheter was inserted into the femoral artery and the tip of the probe was advanced to the lower abdominal aorta as done previously 3 . Readings for each BP parameter was collected for a 24-hour period (5 minute time intervals for 10 seconds) at 4 week intervals. For collection of urine, rats were kept in metabolism cages (Lab Products, Seaford, Delaware) for 24 hours with free access to water 1, 4 . The animals were subsequently euthanized and heart and kidney weights were measured. The left kidney was processed for histological analysis.
Study 4: Glomerular Permeability and Number. The reflection coefficient of albumin (σalb was determined in isolated glomeruli from S and S.SHR(2)X39 raised on low-salt diet (week 12) using modifications of the Savin technique 5 . Rats were anesthetized with isoflurane and a catheter was inserted into the femoral vein for the infusion of a high molecular weight FITClabeled dextran (75mg/kg) which remains in the glomerular capillaries and is not filtered. After 5 min, glomeruli were isolated using the sieving method in Hank's buffer solution containing 6% bovine serum albumin (BSA) and then transferred to 80 µL fast-exchange perfusion chamber mounted on the stage of an inverted microscope (TS100, Nikon Inc., Melville, NY). The FITClabeled dextran localized in the glomeruli was imaged with the InCyt IM1 imaging system (Intracellular Imaging, Cincinnati, OH) using an excitation filter of 475 nm and an emission filter of 530 nm. σAlb was determined by measuring the changes in fluorescence in each glomeruli after lowering the concentration of BSA in the bath from 6 to 4%. σalb was calculated as % change of fluorescent intensity divided expected % change in glomerular volume relative to the 66% decrease in oncotic pressure). These experiments were performed using 4-5 rats per strain on a minimum of 20 glomeruli per rat (n=80-100 total glomeruli per group).
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The determination of glomeruli number was performed using direct maceration/counting method 6 . Glomeruli were harvested from S and S.SHRX39 at two time points (week 6 and week 12). Kidneys were minced into fine cubes and the fragments were incubated in 5 ml of 6 M HCl at 37°C for 1.5 hours. The tissue was homogenized through repeated pipetting, and 45 ml of PBS was added. The homogenate was incubated overnight at 4°C at which time glomeruli were counted in triplicate from 1 ml aliquots using light microscopy. Total glomerular number per kidney was extrapolated mathematically.
Study 5: Renal Function and Survival Curve. At 4 weeks of age, groups of age matched male S and S.SHR(2)X39 animals (n=9 per group) were weaned to a normal rodent chow (0.7% NaCl;
Purina 5010) to exacerbate hypertension and progression of injury compared to low-salt diet.
Proteinuria was determined at week 8 and 12. At week 12, the 24-hour urine collection was followed by blood collection via the tail for determination of creatinine and calculation of creatinine clearance (CrCl). Animals were subsequently euthanized and heart and kidney weights were measured. The left kidney was removed and cortex and medulla were dissected and snap frozen in liquid nitrogen for gene expression studies (e.g. isolation RNA) and western blot analysis. The right kidney was placed in buffered formalin for histological examination. An additional group of animals were used to study survival. Male S, S.SHR(2)X39, and SHR rats (n=12 rats per group) were maintained on Purina 5010 diet until the rats died. Animals were examined twice daily and were euthanized if they displayed signs of distress (e.g. shaking, lethargy, persistent lateral recumbency, or respiratory distress).
RBF autoregulation was evaluated in a separate group of animals raised on normal rodent diet (n=7-8 per group). Animals were anesthetized using isoflurane for placement of catheter into the femoral artery. The catheter was tunneled subcutaneously under the skin and emerged at the base of the neck. After 24-hours, MAP was measured in conscious freely moving rat for 10 minutes.
Subsequently, animals were anesthetized with ketamine (30 mg/kg) and Inactin (50 mg/kg) and maintained at 37°C. A catheter was placed into the femoral vein for infusion of 2% BSA in a 0.9% NaCl solution at a rate of 100 µL/min. The left kidney was exposed and the left ureter was cannulated for collection of urine. Clamps were placed around the abdominal aorta and ligatures placed around the celiac and mesenteric arteries so that renal perfusion pressure (RPP) could be varied by adjusting peripheral resistance Study 6: Pharmacological inhibition of Rho-Rock pathway. At 4 weeks of age, groups of age matched male S, S.SHR(2)X39, and SHR animals (n=11 per group) were weaned onto low-salt diet (0.3% NaCl). At week 8, animals in each group were randomly assigned to either control (n=5 per strain) or fasudil treatment (n=6 per strain). Animal were provided fasudil (LC Laboratories, MA) in drinking water from week 8 to week 12. Drinking volume was assessed every 2-3 days and the concentration of fasudil was adjusted to achieve a dose of ~20 mg/kg/day.
Proteinuria was determined at week 8, 10, and 12 after 24-hour urine collection. Subsequently, animals were euthanized and heart and kidney weights were measured.
Histological Assessment
Kidney tissue was fixed in zinc formalin and embedded in paraffin, cut into 4-μm sections and stained with hematoxylin and eosin (H&E) and/or Masson's trichrome. At least two central longitudinal sections from each kidney were examined in a blinded fashion. Glomerular injury was assessed using a semi-quantitative scoring system in 20 randomly selected images (H&E at 40X) as previously described 2, 8 . Immunohistochemistry was performed on unstained sections, deparaffinized with xylene and ethanol, and incubated with proteinase K for antigen retrieval. Endogenous biotin and peroxidase activity was blocked by incubation with avidin and biotin, and hydrogen peroxide, respectively.
Primary anti-α-SMA (Santa Cruz Biotech) or anti-CD68 (Serotec, Inc) were used, followed by incubation with horse anti-mouse secondary antibody (Vectastain ABC kits; Vector Laboratory, Burlingame, CA) and 0.02% H 2 O 2 + 0.1% diaminobenzidine tetrahydrochloride (DAB). The slides were lightly counterstained with aniline blue dye and photographed under the microscope.
Images were captured using Nikon 55i microscope with DS-Fi1 5-Meg Color C digital camera (Nikon, Melville, NY) and analyzed using Nis-Elements image analysis software (version 3.03, Nikon Instruments Inc., Melville, NY).
Molecular Methods
Genotyping and Sequencing. Genomic DNA was obtained by tail biopsy or liver for development of congenic strains or sequencing and prepared using Wizard SV 96 Genomic DNA kit (Promega, San Luis Obispo, CA). Genotyping was done using a fluorescent-based approach 8 on a Beckman Coulter CEQ8000 XL capillary sequencer as described in detail previously 1 . The coding region of genes (highlighted region Table S4 ) was sequenced from cDNA, except for Hapln2 and Paqr6 which were sequenced from genomic DNA. Primers were designed from known databases (www.ncbi.nlm.nih.gov or www.ensembl.org) ( Table S2 ) to amplify the fulltranscript. RNA was extracted using Trizol® reagent (Invitrogen, Carlsbad, CA) and purified using Mini RNeasy kit (Qiagen,Valencia, CA ) according to manufacturer's protocol. cDNA was prepared by reverse transcription using the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA). PCR products were cloned into a TOPO TA sequencing vector (Invitrogen, Carlsbad, CA) and transformed into TOP10 E. Coli. Plasmid DNA was isolated using the Purelink™ Quick96 Plasmid Kit (Invitrogen, Carlsbad, CA), evaluated for quality and quantity and sequencing using standard automated fluorescence-based DNA sequencing.
Sequencing reads were assessed for quality and aligned to the BN reference sequence using the DNASTAR's Lasergene v7.2 software package. All SNP and insertion-deletions (INDEL) were visually confirmed in the trace files. All identified variants were verified by direct sequencing from genomic DNA isolated from at least two rats per strain (S or SHR).
Real-Time PCR and Multiplex Gene Expression. RNA was extracted using Trizol® reagent as described above. cDNA was obtained by reverse transcription using the SuperScript III FirstStrand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA). Gene expression was evaluated using the using SYBR-green dye chemistry on a Stratagene MX3000p Real-Time PCR machine or Bio-Rad CFX96 (minimum n=6 each strain) and using Beckman Coulter GeXP platform. For RT-PCR, gene expression between the congenic strain and its control were evaluated using the comparative method (∆∆Ct) using GAPDH and/or β-Actin as "housekeeping" control genes (Table S6) . For the GeXP platform, multiplex RT-PCR involved 9 two stages: (1) reverse transcription and amplification from RNA (GeXP Start Kit protocol) using chimeric primers, in this case directed at all 26 genes within the QTL (including GAPDH and β-Actin as control genes). PCR primers were designed to yield PCR products 4 to 7 bp apart, ranging from 137 to 338 bp (Table S7) using GeXP Express Profiler Primer Design Module (Beckman, Fullerton, CA); and (2) amplification using a single pair of universal primers as used by others 9, 10 . The products obtained from multiplex amplification were analyzed using the Beckman GeXP Platform. The peak location represents the gene identity, and the peak area between-laboratory variation as previously described 13 . eGFR was estimated using the Modification of Diet in Renal Disease (MDRD) equation 14 . We also evaluated associations with albuminuria using urine albumin to creatinine ratio (UACR, mg/g). Genotyping quality control was conducted centrally and is described elsewhere 11 . Study-specific principal components were estimated using EIGENSTRAT 15 . We identified 22 SNPs within the region of interest.
Study-specific residuals from linear regression models of natural log-transformed eGFR or UACR were adjusted for age, sex and study site (if needed). The residuals were regressed into genotypes using additive genetic models while adjusting for 10 principal components. A linear regression approach was used that modeled the conditional probability distribution of the trait given genotype (SNPs) dosage. Models were fitted using the least 11 squares approach (parametric model). Relatedness (family data) was accounted for using linear mixed effect (LME) models. Meta-analyses of study-specific results were then performed using an inverse variance weighted fixed effect model (implemented in METAL, at www.sph.umich.edu/csg/abecasis/Metal/). Significant findings are reported using Bonferroni adjustments for 22 SNP tested (p<0.002).
The SNP selection was based on the target region based on the fine-mapping and experimental finding for the rat studies. We selected 22 genotyped SNPs that passed quality control and mapped homologous region in human genes of interest or their intergenic regions.
(ARHGEF11, PEAR1, SH2D2A, and NES). The most significantly associated SNP, rs7534418, is an intronic variant of the neurotrophic tyrosine kinase, receptor, type 1 gene.
This SNP is in strong LD (r2=0.73, D'=0.87 in CEU 1000 Genome Pilot Data) with a nonsynonymous variant in the SH2D2A gene, rs926103 (not available in our data and predicted benign in Polyphen), and in moderate LD with rs2182761, an intronic variant of SH2D2A (r2=0.63, D' 0.86). We now include this information in the result section. CC  TT  TT  TT  CC  TT  TT  CC  CC  CC  TT  TT  SNP2786642 178871056 C/T  TT  CC  CC  TT  CC  CC  TT  TT  TT  CC  CC  CC  SNP2786643 179011247 G/A  GG  GG  GG  GG  GG  AA  AA  GG  GG  GG  GG  GG  SNP2786646 179506095 C/T  TT  TT  TT  TT  TT  CC  CC  TT  TT  TT  TT  CC  SNP2786647 179508457 A/G  GG  AA  AA  AA  GG  AA  AA  GG  GG  GG  AA  AA  SNP2786648 179645084 C/G  GG  CC  GG  GG  CC  CC  CC  CC  CC  CC  GG  CC  SNP2786652 179892073 C/T  CC  CC  CC  CC  TT  TT  TT  TT  TT  TT  TT  CC  CC  SNP2786655 180264633 C/T  CC  TT  CC  CC  TT  CC  CC  TT  CC  TT  CC  CC  CC  SNP2786656 180441222 C/T  CC  CC  CC  CC  CC  TT  TT  CC  CC  CC  CC  CC  SNP2786657 180481614 C/A  CC  CC  CC  CC  CC  AA  AA  CC  CC  CC  CC  CC  SNP2786660 180513367 T/A  AA  AA  AA  AA  AA  TT  AA  AA  AA  AA  AA  analyzed (2); www.pga.mcw.edu] for proteinuria. No QTL for proteinuria was observed in either linkage study, consistent with the same variant being present (FHH=ACI= T allele; MWF=LEW=C allele) and no significant difference in proteinuria was observed in the congenic, consistent with the finding that the same variant is present for S and BN. It is important to note that this SNP is in itself is likely not causative, but closely linked to the genetic variant(s) that are causative. Figure S1 : Schematic diagram of the approach used to narrow gene/ genetic variants associated with kidney injury on rat chromosome 2. The predominant method was substitution analysis using recombinant progeny testing (RPT) and/or congenic strain analysis. The use of other methods, such as haplotype analysis, comparative mapping, and linkage or genome-wide association studies (GWAS) in humans was used to further refine the likely location of the QTL.
SUPPLEMENTAL TABLES
SUPPLEMENTAL FIGURES AND LEGEND
Once the number of genes were narrowed to a manageable number (~20-30), sequencing, gene expression, and bioinformatics analysis was performed to identify strong candidate genes that can be further studied in vivo by genetic modification (e.g., gene knockout) or by pharmacological agents. Table S1 . Based on RPT, the QTL interval was narrowed to genomic region defined to D2Rat131-D2Rat230 (~2.75 Mb). The S.SHR(2)X39 recombinant family was used to generate a congenic strain that fixed the transferred genomic interval homozygous SHR/SHR (Fig. 1) . The S.SHR(2)X47 was generated from a new recombination that occurred while developing the S.SHR(2)X39 strain. These fixed congenic strain were phenotyped for other measures of kidney injury and function (Studies 2-6 ). Nephron/glomeruli number. Measurements were made at week 12 (n=8 per group), except for nephron number which was also evaluated week 6.*, p<0. 05. The benefit to this approach is the ability measure gene expression patterns of genes within the Figure S6 : Decision tree used to establish top candidate genes based on three classifications: (1) nature and type of sequence variants; (2) differential expression; and (3) potential biological significance. Depending on the path (no or yes), genes were classified as low priority (shown in red), medium priority (shown in yellow), or high priority (shown in green). A gene that exhibited "high priority" designation in each classification is considered an important gene for additional study. Thus, a gene that is denoted as high priority for every classification (1. sequence variants, 2. expression, and 3. biological significance) is assumed to have highest probability to play a functional role, more so than other genes in the genomic interval designated as low or medium priority. 
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